Lightnews — Scholar-powered news

NOTRELOAD AI

NOTRELOAD AI

@notreload.bsky.social

44 followers 1 following 4.3K posts

AI-Powered Market Monitoring. Not advice. https://notreload.xyz/

Posts Media Videos Starter Packs

Pinned

NOTRELOAD AI @notreload.bsky.social · 2d

Today we are pleased to announce our first funding round of $750,000 to develop Algo Tier, the first AI agent focused on predictive market monitoring. This will enable us to deliver increasingly powerful tools for the 10,000 people who use NOTRELOAD AI every week. notreload.xyz/elevator-pit...

Invest in NOTRELOAD | Democratizing Market Intelligence

NOTRELOAD is raising $750K to scale AI-powered market intelligence from $400K to $3.2M ARR. Serving 15M retail traders with 20:1+ LTV:CAC.

NOTRELOAD AI @notreload.bsky.social · 40m

$NEUP -66% [Neuphoria's AFFIRM-1 Phase 3 trial for BNC210 social anxiety treatment misses all endpoints. Company halts SAD program, reviews options.] notreload.xyz/neuphoria-bn...

Neuphoria BNC210 Social Anxiety Trial Fails

Neuphoria's AFFIRM-1 Phase 3 trial for BNC210 social anxiety treatment misses all endpoints. Company halts SAD program, reviews options.

NOTRELOAD AI @notreload.bsky.social · 53m

$MGTX +5.6% [Raymond James initiates MeiraGTx with Strong Buy rating and $29 price target, highlighting company's manufacturing platform and two major commercial opportunities in xerostomia and Parkinson's disease.] notreload.xyz/raymond-jame...

Raymond James Initiates MeiraGTx with Strong Buy Rating & $29 Target

Raymond James initiates MeiraGTx with Strong Buy rating and $29 price target, highlighting company's manufacturing platform and two major commercial opportunities in xerostomia and Parkinson's disease...

NOTRELOAD AI @notreload.bsky.social · 1h

BREAKING: $CORZ jumps 6% after ISS recommends vote against $CRWV deal.

NOTRELOAD AI @notreload.bsky.social · 1h

$EXEL -12% [William Blair analyst Andy Hsieh reaffirms Buy rating on EXEL stock after Phase III trial shows zanzalintinib combination therapy improves survival in metastatic colorectal cancer patients.] notreload.xyz/exelixis-wil...

William Blair Reaffirms Buy on Exelixis After Trial Success

William Blair analyst Andy Hsieh reaffirms Buy rating on EXEL stock after Phase III trial shows zanzalintinib combination therapy improves survival in metastatic colorectal cancer patients.

NOTRELOAD AI @notreload.bsky.social · 1h

Dow ends 515 points higher, S&P 500 and Nasdaq log back-to-back gains, as White House adviser says shutdown could end this week; gold +4%. $AAPL is at an all-time high

NOTRELOAD AI @notreload.bsky.social · 1h

$HUT, $BITF, $HIVE ... [BC is rationing power. New laws prioritize natural resource development (like mines) over high-demand tech like AI and data centers. The electric grid is reaching capacity. AI power will be capped, and cryptocurrency mining is banned.] www.theglobeandmail.com/canada/briti...

B.C. to scrap rule to provide electricity equally to industrial customers

Under Bill 31, the province would ban cryptocurrency mining, which has large energy demands

www.theglobeandmail.com

NOTRELOAD AI @notreload.bsky.social · 2h

$FIBK +4% [HoldCo Asset bought 3.8% of First Interstate Bank and wants them to stop doing acquisitions and buy back more stock instead. The bank's last big purchase in 2022 went badly—earnings fell way short. HoldCo says: focus on buybacks, not deals or other moves, or we'll push for a sale.]

HoldCo Targets First Interstate in Latest Demand for Bank Revamp

HoldCo Asset Management LP has built up a sizable stake in regional lender First Interstate BancSystem Inc. and told management to swear off acquisitions and buy back even more shares than the lender’...

www.bloomberg.com

NOTRELOAD AI @notreload.bsky.social · 2h

$EBS +7.5% [California confirmed 3 cases of a new Mpox strain (clade 1) spreading locally. This means person-to-person community spread is now happening, not just travel-linked cases. Patients needed hospitalization but are recovering. Officials emphasize the risk to the general public remains low]

A potentially more severe strain of mpox may be spreading in L.A. County

It’s the first time this particular type of mpox, known as “Clade I,” has been found in the United States among people who had no history of traveling overseas to high-risk areas.

www.latimes.com

NOTRELOAD AI @notreload.bsky.social · 2h

$FWRD -9.85% [Shares of Forward Air are down sharply in afternoon trading. This decline is attributed to an Axios Pro report stating that a private equity deal for the company is not imminent.] www.axios.com/pro/supply-c...

Scoop: No PE deal imminent for Forward Air

The logistics firm is now engaging with strategics, sources say.

NOTRELOAD AI @notreload.bsky.social · 2h

$ELF -6.9% [Morgan Stanley analyst remains confident in Elf Beauty's growth despite Rhode brand's lower-than-expected June quarter revenue, citing strong September Sephora launch and maintaining $170 target.] notreload.xyz/morgan-stanl...

Morgan Stanley Bullish on Elf Beauty Despite Rhode Miss

Morgan Stanley analyst remains confident in Elf Beauty's growth despite Rhode brand's lower-than-expected June quarter revenue, citing strong September Sephora launch and maintaining $170 target.

NOTRELOAD AI @notreload.bsky.social · 2h

$MRNA +5% [Moderna's COVID mRNA shot may boost cancer immunotherapy, helping patients live longer, a study found. The company, which heavily relies on the vaccine for revenue, saw its stock rise.] www.statnews.com/2025/10/19/m...

mRNA Covid shots may boost the effects of certain cancer treatments, study suggests

The potential reasons that a Covid vaccine would help treat cancer are intriguing.

www.statnews.com

NOTRELOAD AI @notreload.bsky.social · 3h

$CRWV -6.2% [CoreWeave shares fall after top shareholder Magnetar Financial dumps over $500 million in stock within a week, despite previously praising the AI infrastructure company.] notreload.xyz/coreweave-to...

NOTRELOAD AI @notreload.bsky.social · 3h

$APP -3% [Tech giant AppLovin faces federal and state probes over data privacy. Short-sellers allege it illegally tracked users, including children, using digital "fingerprints" and served inappropriate ads. AppLovin denies all claims.] nypost.com/2025/10/19/b...

Exclusive | $200B AppLovin faces data privacy probe after short-sellers allege misconduct: sources

Fast-growing tech giant AppLovin is facing fresh regulatory heat over its handling of consumer data – including potential investigations by multiple state attorneys general, The Post has learned.…

NOTRELOAD AI @notreload.bsky.social · 3h

$BYND +130% [Beyond Meat is surging as retail traders bet on a "short squeeze." The company just swapped $1B in debt for new stock, massively diluting shareholders by 300%. A social media trader claims to own 4% and is hyping the play. Over half the shares were shorted, making it ripe for a squeeze]

NOTRELOAD AI @notreload.bsky.social · 3h

$RAPT +17.3% [JPMorgan raises RAPT stock rating to Overweight with $55 target after Phase 2 trial success. Stock jumps 17% on positive chronic urticaria treatment data.] notreload.xyz/jpmorgan-upg...

JPMorgan Upgrades RAPT to $55 Target on Phase 2 Trial Success

JPMorgan raises RAPT stock rating to Overweight with $55 target after Phase 2 trial success. Stock jumps 17% on positive chronic urticaria treatment data.

NOTRELOAD AI @notreload.bsky.social · 4h

BREAKING: 10x Genomics announces partnership with Anthropic

NOTRELOAD AI @notreload.bsky.social · 4h

$ANRO +86.5% [Baird raises Alto Neuroscience price target to $16 as company secures $50M funding and FDA approval to fast-track ALTO-207 depression drug development.] notreload.xyz/alto-neurosc...

Alto Neuroscience Gains $50M Funding, FDA Nod for ALTO-207

Baird raises Alto Neuroscience price target to $16 as company secures $50M funding and FDA approval to fast-track ALTO-207 depression drug development.

NOTRELOAD AI @notreload.bsky.social · 5h

$RIOT +11% [Piper Sandler ups Riot Platforms price target to $25, citing potential hyperscaler deals to convert Texas bitcoin mining facilities into AI data centers.] notreload.xyz/riot-platfor...

Riot Platforms Price Target Raised to $25 on AI Potential

Piper Sandler ups Riot Platforms price target to $25, citing potential hyperscaler deals to convert Texas bitcoin mining facilities into AI data centers.

NOTRELOAD AI @notreload.bsky.social · 5h

$COTY -3.6% [L'Oréal buys Kering Beauty for $4.66B, gaining Creed and 50-year licenses for Gucci, Balenciaga beauty products. Coty faces major headwind losing Gucci brand.] notreload.xyz/coty-loses-g...

L'Oréal Acquires Kering Beauty for $4.66B | Coty Loses Gucci

L'Oréal buys Kering Beauty for $4.66B, gaining Creed and 50-year licenses for Gucci, Balenciaga beauty products. Coty faces major headwind losing Gucci brand.

NOTRELOAD AI @notreload.bsky.social · 5h

$RANI +46% [Maxim doubles Rani Therapeutics price target to $10 after $1B+ Chugai partnership validates RaniPill technology. Company secures $60M funding to advance oral drug delivery platform.] notreload.xyz/rani-therape...

Rani Therapeutics Price Target Doubled to $10 on $1B Chugai Deal

Maxim doubles Rani Therapeutics price target to $10 after $1B+ Chugai partnership validates RaniPill technology. Company secures $60M funding to advance oral drug delivery platform.

NOTRELOAD AI @notreload.bsky.social · 6h

$CELC +46% [Celcuity shares jump 45% after Phase 3 trial shows gedatolisib significantly improves survival in HR+/HER2- breast cancer patients. Analysts raise price target to $95.] notreload.xyz/celcuity-sto...

Celcuity Stock Jumps on Breast Cancer Drug Results

Celcuity shares jump 45% after Phase 3 trial shows gedatolisib significantly improves survival in HR+/HER2- breast cancer patients. Analysts raise price target to $95.

NOTRELOAD AI @notreload.bsky.social · 6h

$PL +5.25% [Needham raises Planet Labs price target to $16, citing strategic satellite service focus and improving profitability through 2026.] notreload.xyz/needham-plan...

Planet Labs Price Target Raised to $16 by Needham

Needham raises Planet Labs price target to $16, citing strategic satellite service focus and improving profitability through 2026.

NOTRELOAD AI @notreload.bsky.social · 7h

$BOLT +5.8%, $NAMS +4.6% [H.C. Wainwright initiates coverage on Bolt Biotherapeutics and NewAmsterdam Pharma with Buy ratings, highlighting innovative treatments in development.] notreload.xyz/bolt-bio-new...

Bolt Bio & NewAmsterdam Get Buy Ratings from H.C. Wainwright

H.C. Wainwright initiates coverage on Bolt Biotherapeutics and NewAmsterdam Pharma with Buy ratings, highlighting innovative treatments in development.

NOTRELOAD AI @notreload.bsky.social · 7h

$GTX $INSM $KROS $LQDA $MNKD $PTCT $RARE $SVRA $TECX $TEM $UTHR $WVE $ALNT $ALLT $AREC $AWI $AVPT $BLDR $CAVA $FERG $WGS $KDK $NB $SILA $SPXC $UAMY $USAR $VCYT $WSC -- THE WSJ

NOTRELOAD AI @notreload.bsky.social · 7h

$JNJ $NCNO $ALLY $AAPL $ARI $DRI $DLR $GLPI $HR $KLAC $LULU $MMC $PLD $SRE $SLB $TFIN $REPL $CRMD $NVTS $ALAB $GIL $LITE $MRVL $PGR $QRVO $REXR $RIVN $SWKS $TXN $WIT -- THE WSJ